Switch to
More onapp

Aarey Drugs and Pharmaceuticals Ltd

AAREYDRUGS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹99 cr, stock is ranked 2,175
High RiskStock is 3.09x as volatile as Nifty
38.850.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹99 cr, stock is ranked 2,175
High RiskStock is 3.09x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
15.14
PB RatioPB Ratio
0.87
Dividend YieldDiv. Yield
Sector PESector PE
34.97
Sector PBSector PB
4.27
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Aarey Drugs & Pharmaceuticals is engaged in active pharmaceutical ingredient (API)/Bulk Drugs manufacturing.

Financial TrendFinancial statements 

2019202020212022359.08306.78355.43495.436.555.796.526.54
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 1.98%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Annual General Meeting 
Announced OnOct 1, 2022

Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Scrutinizer report of Annual General Meeting held on 30-Sep-2022 | Download

Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Scrutinizer report of Annual General Meeting held on 30-Sep-2022 | Download

Annual General Meeting 
Announced OnSep 30, 2022

Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Proceedings of Annual General Meeting held on 30-Sep-2022 | Download

Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Proceedings of Annual General Meeting held on 30-Sep-2022 | Download

Cash Dividend 
Ex. DateDec 13, 2018

Interim • Div/Share: ₹ 0.1

See all events